Late morbidity associated with a tumour-negative sentinel lymph node biopsy in primary breast cancer patients: A systematic review

European Journal of Cancer

Volumn 45, Issue 9, 2009, Pages 1560-1568

  Liu, Chao qian ^a   Guo, Yan ^a   Shi, Jun yi ^a   Sheng, Yuan ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Axillary lymph node dissection; Breast neoplasms; Morbidity; Sentinel lymph node biopsy; Systematic review

Indexed keywords

ANTINEOPLASTIC AGENT; DYE; RADIOPHARMACEUTICAL AGENT;

ARTICLE; BODY MASS; BREAST CANCER; BREAST SURGERY; CANCER PAIN; CONSERVATIVE TREATMENT; EDEMA; HORMONAL THERAPY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; LYMPHOSCINTIGRAPHY; MASTECTOMY; MORBIDITY; PAIN ASSESSMENT; PREDICTION; PREVALENCE; PRIMARY TUMOR; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; RANGE OF MOTION; SENSORY DYSFUNCTION; SENTINEL LYMPH NODE BIOPSY; SYSTEMATIC REVIEW; TUMOR LOCALIZATION;

BREAST NEOPLASMS; EDEMA; EVIDENCE-BASED MEDICINE; FEMALE; HUMANS; LYMPH NODE EXCISION; LYMPHATIC METASTASIS; MUSCLE STRENGTH; PAIN; RANGE OF MOTION, ARTICULAR; SENSATION DISORDERS; SENTINEL LYMPH NODE BIOPSY; SHOULDER JOINT;

EID: 65849338576     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2009.02.012     Document Type: Article

References (62)

1. Krag D.N., Weaver D.L., Alex J.C., and Fairbank J.T. Surgical resection and radiolocalization of the sentinel lymph node in breast cancer using a gamma probe. Surg Oncol 2 (1993) 335-339
2. Veronesi U., Paganelli G., Viale G., et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. New Engl J Med 349 (2003) 546-553
3. Giuliano A.E., Kirgan D.M., Guenther J.M., and Morton D.L. Lymphatic mapping and sentinel lymphadenectomy for breast cancer. Ann Surg 225 (1997) 126-127
4. Krag D., Weaver D., Ashikaga T., et al. The sentinel node in breast cancer - a multicenter validation study. New Engl J Med 339 (1998) 941-946
5. Veronesi U., Paganelli G., Galimberti V., et al. Sentinel-node biopsy to avoid axillary dissection in breast cancer with clinically negative lymphnodes. Lancet 349 (1997) 1864-1867
6. Kim T., Giuliano A.E., and Lyman G.H. Lymphatic mapping and sentinel lymph node biopsy in early-stage breast carcinoma. Cancer 106 (2006) 4-16
7. de Kanter A.Y., Menke-Pluymers M.M., and Wouters M.W. 5-Year follow-up of sentinel node negative breast cancer patient. Eur J Surg Oncol 32 (2006) 282-286
8. Domènech A., Benitez A., Bajén M.T., Pla M.J., Gil M., and Martín-Comín J. Patients with breast cancer and negative sentinel lymph node biopsy without additional axillary lymph node dissection: a follow-up study of up to 5 years. Oncology 72 (2007) 27-32
9. Veronesi U., Galimberti V., Mariani L., et al. Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissection. Eur J Cancer 41 (2005) 231-237
10. Naik A.M., Fey J., Gemignani M., et al. The risk of axillary relapse after sentinel lymph node biopsy for breast cancer is comparable with that of axillary lymph node dissection: a follow-up study of 4008 procedures. Ann Surg 240 (2004) 462-468
11. van der Ploeg I.M., Nieweg O.E., van Rijk M.C., Valdés Olmos R.A., and Kroon B.B. Axillary recurrence after a tumour-negative sentinel node biopsy in breast cancer patients: a systematic review and meta-analysis of the literature. Eur J Surg Oncol 34 (2008) 1277-1284
12. Kuijt G.P., van de Poll-Franse L.V., Voogd A.C., Nieuwenhuijzen G.A., and Roumen R.M. Survival after negative sentinel lymph node biopsy in breast cancer at least equivalent to after negative extensive axillary dissection. Eur J Surg Oncol 33 (2007) 832-837
13. Mansel R.E., Fallowfield L., Kissin M., et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J Natl Cancer Inst 98 (2006) 599-609
14. Langer I., Guller U., Berclaz G., et al. Morbidity of sentinel lymph node biopsy (SLNB) alone versus SLNB and completion axillary lymph node dissection after breast cancer surgery: a prospective Swiss multicenter study on 659 Patients. Ann Surg 245 (2007) 452-461
15. Husted Madsen A., Haugaard K., Soerensen J., et al. Arm morbidity following sentinel lymph node biopsy or axillary lymph node dissection: a study from the Danish Breast Cancer Cooperative Group. Breast 17 (2008) 138-147
16. Crane-Okada R., Wascher R.A., Elashoff D., and Giuliano A.E. Long-term morbidity of sentinel node biopsy versus complete axillary dissection for unilateral breast cancer. Ann Surg Oncol 15 (2008) 1996-2005
17. Bruner D.W., and Wasserman T. The impact on quality of life by radiation late effects. Int J Radiat Oncol Biol Phys 31 (1995) 1353-1355
18. Swedborg I., Borg G., and Sarnelid M. Somatic sensation and discomfort in the arm of post-mastectomy patients. Scand J Rehab Med 13 (1981) 23-29
19. Tobin M.B., Lacey H.J., Meyer L., and Mortimer P.S. The psychological morbidity of breast cancer-related arm swelling. Cancer 72 (1993) 3248-3253
20. Rietman J.S., Dijkstra P.U., Hoekstra H.J., et al. Late morbidity after treatment of breast cancer in relation to daily activities and quality of life: a systematic review. Eur J Surg Oncol 29 (2003) 229-238
21. Scholten-Peeters G.G., Verhagen A.P., Bekkering G.E., et al. Prognostic factors of whiplash-associated disorders: a systematic review of prospective cohort studies. Pain 104 (2003) 303-322
22. Borghouts J.A., Koes B.W., and Bouter L.M. The clinical course and prognostic factors of non-specific neck pain: a systematic review. Pain 77 (1998) 1-13
23. Kuijpers T., van der Windt D.A., van der Heijden G.J., and Bouter L.M. Systematic review of prognostic cohort studies on shoulder disorders. Pain 109 (2004) 420-431
24. Mols F., Vingerhoets A.J., Coebergh J.W., and van de Poll-Franse L.V. Quality of life among long-term breast cancer survivors: a systematic review. Eur J Cancer 41 (2005) 2613-2619
25. Fleissig A., Fallowfield L.J., Langridge C.I., et al. Post-operative arm morbidity and quality of life. Results of the ALMANAC randomised trial comparing sentinel node biopsy with standard axillary treatment in the management of patients with early breast cancer. Breast Cancer Res Treat 95 (2006) 279-293
26. Purushotham A.D., Upponi S., Klevesath M.B., et al. Morbidity after sentinel lymph node biopsy in primary breast cancer: results from a randomized controlled trial. J Clin Oncol 23 (2005) 4312-4321
27. Del Bianco P., Zavagno G., Burelli P., et al. Morbidity comparison of sentinel lymph node biopsy versus conventional axillary lymph node dissection for breast cancer patients: results of the sentinella-GIVOM Italian randomised clinical trial. Eur J Surg Oncol 34 (2008) 508-513
28. Zavagno G., De Salvo G.L., Scalco G., et al. A randomized clinical trial on sentinel lymph node biopsy versus axillary lymph node dissection in breast cancer: results of the Sentinella/GIVOM trial. Ann Surg 247 (2008) 207-213
29. Lucci A., McCall L.M., Beitsch P.D., et al. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011. J Clin Oncol 25 (2007) 3657-3663
30. Rietman J.S., Dijkstra P.U., Geertzen J.H., et al. Treatment-related upper limb morbidity 1 year after sentinel lymph node biopsy or axillary lymph node dissection for stage I or II breast cancer. Ann Surg Oncol 11 (2004) 1018-1024
31. Rietman J.S., Geertzen J.H., Hoekstra H.J., et al. Long term treatment related upper limb morbidity and quality of life after sentinel lymph node biopsy for stage I or II breast cancer. Eur J Surg Oncol 32 (2006) 148-152
32. Swenson K.K., Nissen M.J., Ceronsky C., Swenson L., Lee M.W., and Tuttle T.M. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer. Ann Surg Oncol 9 (2002) 745-753
33. Barranger E., Dubernard G., Fleurence J., Antoine M., Darai E., and Uzan S. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer. J Surg Oncol 92 (2005) 17-22
34. Peintinger F., Reitsamer R., Stranzl H., and Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br J Cancer 89 (2003) 648-652
35. Temple L.K., Baron R., Cody III H.S., et al. Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 9 (2002) 654-662
36. Husen M., Paaschburg B., and Flyger H.L. Two-step axillary operation increases risk of arm morbidity in breast cancer patients. Breast 15 (2006) 620-628
37. Wilke L.G., McCall L.M., Posther K.E., et al. Surgical complications associated with sentinel lymph node biopsy: results from a prospective international cooperative group trial. Ann Surg Oncol 13 (2006) 491-500
38. Leidenius M., Leivonen M., Vironen J., and von Smitten K. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance. J Surg Oncol 92 (2005) 23-31
39. Rönkä R., von Smitten K., Tasmuth T., and Leidenius M. One-year morbidity after sentinel node biopsy and breast surgery. Breast 14 (2005) 28-36
40. Baron R.H., Fey J.V., Raboy S., et al. Eighteen sensations after breast cancer surgery: a comparison of sentinel lymph node biopsy and axillary lymph node dissection. Oncol Nurs Forum 29 (2002) 651-659
41. Baron R.H., Fey J.V., Borgen P.I., and Van Zee K.J. Eighteen sensations after breast cancer surgery: a two-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Oncol Nurs Forum 31 (2004) 691-698
42. Baron R.H., Fey J.V., Borgen P.I., Stempel M.M., Hardick K.R., and Van Zee K.J. Eighteen sensations after breast cancer surgery: a 5-year comparison of sentinel lymph node biopsy and axillary lymph node dissection. Ann Surg Oncol 14 (2007) 1653-1661
43. Schijven M.P., Vingerhoets A.J., Rutten H.J., et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur J Surg Oncol 29 (2003) 341-350
44. Burak W.E., Hollenbeck S.T., Zervos E.E., Hock K.L., Kemp L.C., and Young D.C. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183 (2002) 23-27
45. Schrenk P., Rieger R., Shamiyeh A., and Wayand W. Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88 (2000) 608-614
46. Schulze T., Mucke J., Markwardt J., Schlag P.M., and Bembenek A. Long-term morbidity of patients with early breast cancer after sentinel lymph node biopsy compared to axillary lymph node dissection. J Surg Oncol 93 (2006) 109-119
47. Blanchard D.K., Donohue J.H., Reynolds C., and Grant C.S. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch Surg 138 (2003) 482-487
48. Haid A., Köberle-Wührer R., Knauer M., et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73 (2002) 31-46
49. Haid A., Kuehn T., Konstantiniuk P., et al. Shoulder-arm morbidity following axillary dissection and sentinel node only biopsy for breast cancer. Eur J Surg Oncol 28 (2002) 705-710
50. Sener S.F., Winchester D.J., Martz C.H., et al. Lymphedema after sentinel lymphadenectomy for breast carcinoma. Cancer 92 (2001) 748-752
51. Golshan M., Martin W.J., and Dowlatshahi K. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am Surg 69 (2003) 209-211
52. Asaad M., Tamer M., and Mokbel K. British women's choice between sentinel node biopsy and axillary node clearance for breast cancer. Curr Med Res Opin 19 (2003) 570-574
53. Gan S., Magarey C., Schwartz P., Papadatos G., Graham P., and Vallentine J. Women's choice between sentinel lymph node biopsy and axillary clearance. ANZ J Surg 72 (2002) 110-113
54. Krag D.N. Is axillary dissection needed when the sentinal node is positive? Yes!. J Surg Oncol 97 (2008) 197-198
55. Galper S., Recht A., Silver B., et al. Is radiation alone adequate treatment to the axilla for patients with limited axillary surgery? Implications for treatment after a positive sentinel node biopsy. Int J Radiat Oncol Biol Phys 48 (2000) 125-132
56. .
57. Sakorafas G.H., Peros G., Cataliotti L., and Vlastos G. Lymphedema following axillary lymph node dissection for breast cancer. Surg Oncol 15 (2006) 153-165
58. Krynyckyi B.R., Shafir M.K., Kim S.C., et al. Lymphoscintigraphy and triangulated body marking for morbidity reduction during sentinel node biopsy in breast cancer. Int Semin Surg Oncol 2 (2005) 25
59. Kim S.C., Kim D.W., Moadel R.M., et al. Using the intraoperative hand held probe without lymphoscintigraphy or using only dye correlates with higher sensory morbidity following sentinel lymph node biopsy in breast cancer: a review of the literature. World J Surg Oncol 3 (2005) 64
60. Egger M., Zellweger-Zähner T., Schneider M., Junker C., Lengeler C., and Antes G. Language bias in randomised controlled trials published in English and German. Lancet 350 (1997) 326-329
61. Moher D., Fortin P., Jadad A.R., et al. Completeness of reporting of trials published in languages other than English: implications for conduct and reporting of systematic reviews. Lancet 347 (1996) 363-366
62. Moher D., Pham B., Klassen T.P., et al. What contributions do languages other than English make on the results of meta-analyses?. J Clin Epidemiol 53 (2000) 964-972